Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Antitumor combinations containing a VEGF-inhibiting agent and 5FU or a derivative thereof

Antitumor combinations containing a VEGF-inhibiting agent and 5FU or a derivative thereof

US Patent 8388963 · Granted Mar 5, 2013

Estimated economic value: $70,941,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

VEGF antagonist formulations suitable for intravitreal administration2025
Modified urokinase-type plasminogen activator polypeptides and methods of use2025
Complement factor I-related compositions and methods2024
ß-1,6-glucan therapeutic antibody conjugates2024
VEGF antagonist formulations suitable for intravitreal administration2023
Modified urokinase-type plasminogen activator polypeptides and methods of use2023
IL-6 antagonists and uses thereof2022
Method for predicting the outcome of a treatment with aflibercept of a patient s2021
IL-6 antibodies2021
VEGF antagonist formulations suitable for intravitreal administration2021
VEGF antagonist formulations suitable for intravitreal administration2021
Serum albumin binding molecules2021